MetaADEDB 2.0 @ LMMD
zomepirac
(SEEXPXUCHVGZGU-UHFFFAOYSA-M)
Structure
SMILES
[O-]C(=O)Cc1cc(c(n1C)C(=O)c1ccc(cc1)Cl)C.[Na+]
Molecular Formula:
C15H13ClNNaO3
Molecular Weight:
313.711
Log P:
1.5103
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
62.13
CAS Number(s):
64092-48-4
Synonym(s)
1.
zomepirac
2.
5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetate dihydrate
3.
McN 2783-21-98
4.
Zomax
5.
zomepirac potassium
6.
zomepirac sodium
External Link(s)
MeSHC020549
PubChem Compound16220118
CHEMBLCHEMBL266459
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainCanada Vigilance: 1Canada Vigilance
2Acute kidney injuryCanada Vigilance: 2Canada Vigilance
3AgitationCanada Vigilance: 2Canada Vigilance
4Anaphylactic shockCanada Vigilance: 1Canada Vigilance
5Anaphylactoid ReactionCanada Vigilance: 20Canada Vigilance
6AngioedemaCanada Vigilance: 4Canada Vigilance
7AnxietyCanada Vigilance: 1Canada Vigilance
8ArthralgiaCanada Vigilance: 1Canada Vigilance
9AstheniaCanada Vigilance: 3Canada Vigilance
10AsthmaCanada Vigilance: 1Canada Vigilance
11Back PainCanada Vigilance: 3Canada Vigilance
12BradycardiaCanada Vigilance: 1Canada Vigilance
13Chest discomfortCanada Vigilance: 1Canada Vigilance
14Cold sweatCanada Vigilance: 1Canada Vigilance
15ConjunctivitisCanada Vigilance: 2Canada Vigilance
16DehydrationCanada Vigilance: 1Canada Vigilance
17DisorientationCanada Vigilance: 2Canada Vigilance
18DizzinessCanada Vigilance: 5Canada Vigilance
19DysuriaCanada Vigilance: 2Canada Vigilance
20EcchymosisCanada Vigilance: 1Canada Vigilance
21EpistaxisCanada Vigilance: 1Canada Vigilance
22ErythemaCanada Vigilance: 2Canada Vigilance
23FlushingCanada Vigilance: 1Canada Vigilance
24GastritisCanada Vigilance: 1Canada Vigilance
25Genital painCanada Vigilance: 4Canada Vigilance
26HeadacheCanada Vigilance: 6Canada Vigilance
27HyperkinesiaCanada Vigilance: 1Canada Vigilance
28HypotensionCanada Vigilance: 5Canada Vigilance
29LaryngospasmCanada Vigilance: 1Canada Vigilance
30MalaiseCanada Vigilance: 2Canada Vigilance
31NauseaCanada Vigilance: 3Canada Vigilance
32NeutropeniaCanada Vigilance: 1Canada Vigilance
33Optic NeuritisCanada Vigilance: 1Canada Vigilance
34PallorCanada Vigilance: 2Canada Vigilance
35PalpitationsCanada Vigilance: 1Canada Vigilance
36PharyngitisCanada Vigilance: 1Canada Vigilance
37PolyuriaCanada Vigilance: 3Canada Vigilance
38PruritusCanada Vigilance: 13Canada Vigilance
39PurpuraCanada Vigilance: 1Canada Vigilance
40Rash erythematousCanada Vigilance: 4Canada Vigilance
41Renal painCanada Vigilance: 2Canada Vigilance
42Respiratory DepressionCanada Vigilance: 1Canada Vigilance
43Respiratory arrestCanada Vigilance: 1Canada Vigilance
44SomnolenceCanada Vigilance: 3Canada Vigilance
45StuporCanada Vigilance: 1Canada Vigilance
46SyncopeCanada Vigilance: 2Canada Vigilance
47TachycardiaCanada Vigilance: 2Canada Vigilance
48ThirstCanada Vigilance: 1Canada Vigilance
49ThrombocytopeniaCanada Vigilance: 1Canada Vigilance
50TinnitusCanada Vigilance: 2Canada Vigilance
51UrticariaCanada Vigilance: 12Canada Vigilance
52VertigoCanada Vigilance: 1Canada Vigilance
53Visual ImpairmentCanada Vigilance: 1Canada Vigilance
54VomitingCanada Vigilance: 6Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.